STOCK TITAN

[8-K] Cantor Equity Partners, Inc. Reports Material Event

Filing Impact
(High)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

eHealth, Inc. (EHTH) filed an 8-K announcing a planned CEO transition. Current CEO Fran Soistman will step down immediately prior to a Board meeting on 18 Sep 2025 and remain as executive advisor through 31 Dec 2025. The Board has appointed Derrick Duke, 58, former CEO of Magellan Health and ex-CFO/COO of HealthMarkets, as successor CEO and principal executive officer. Duke joins 4 Aug 2025 to begin hand-off; Board membership is expected to follow.

Duke’s offer letter provides: (i) $700 k annual base salary, (ii) 120 % target annual bonus, (iii) $600 k sign-on bonus (claw-back if he leaves within one year), (iv) 300 k time-based RSUs vesting over three years and 300 k performance-based RSUs tied to a three-year program. A severance agreement grants 24 months’ salary, prorated bonus, up to 18 months’ COBRA and partial or full equity acceleration upon a “qualifying termination,” with enhanced cash (24 mo. salary + 200 % target bonus) and full vesting if termination occurs within a year after a change-in-control. A press release (Ex. 99.1) was furnished on 29 Jul 2025.

eHealth, Inc. (EHTH) ha presentato un modulo 8-K annunciando una prevista transizione del CEO. L'attuale CEO, Fran Soistman, si dimetterà immediatamente prima della riunione del Consiglio del 18 settembre 2025 e rimarrà come consulente esecutivo fino al 31 dicembre 2025. Il Consiglio ha nominato Derrick Duke, 58 anni, ex CEO di Magellan Health e ex CFO/COO di HealthMarkets, come nuovo CEO e principale dirigente esecutivo. Duke entrerà in carica il 4 agosto 2025 per iniziare il passaggio di consegne; è previsto anche il suo ingresso nel Consiglio.

La lettera di offerta a Duke prevede: (i) uno stipendio base annuo di 700.000 dollari, (ii) un bonus annuale target del 120%, (iii) un bonus di benvenuto di 600.000 dollari (con possibilità di restituzione se lascia entro un anno), (iv) 300.000 RSU basate sul tempo con maturazione in tre anni e 300.000 RSU basate sulle performance legate a un programma triennale. Un accordo di buonuscita garantisce 24 mesi di stipendio, bonus proporzionato, fino a 18 mesi di COBRA e accelerazione parziale o totale delle azioni in caso di “licenziamento qualificato”, con un aumento in denaro (24 mesi di stipendio + 200% del bonus target) e piena maturazione se il licenziamento avviene entro un anno da un cambio di controllo. Un comunicato stampa (Ex. 99.1) è stato fornito il 29 luglio 2025.

eHealth, Inc. (EHTH) presentó un formulario 8-K anunciando una transición planificada del CEO. El actual CEO, Fran Soistman, renunciará inmediatamente antes de la reunión de la Junta el 18 de septiembre de 2025 y permanecerá como asesor ejecutivo hasta el 31 de diciembre de 2025. La Junta ha nombrado a Derrick Duke, de 58 años, ex CEO de Magellan Health y ex CFO/COO de HealthMarkets, como sucesor y principal ejecutivo. Duke se incorporará el 4 de agosto de 2025 para iniciar la transición; se espera que también se una a la Junta.

La carta oferta para Duke incluye: (i) un salario base anual de 700,000 dólares, (ii) un bono anual objetivo del 120%, (iii) un bono de incorporación de 600,000 dólares (con devolución si se va en menos de un año), (iv) 300,000 RSU basadas en tiempo que se consolidan en tres años y 300,000 RSU basadas en desempeño vinculadas a un programa de tres años. Un acuerdo de indemnización ofrece 24 meses de salario, bono prorrateado, hasta 18 meses de COBRA y aceleración parcial o total de acciones en caso de una “terminación calificada”, con un beneficio en efectivo mejorado (24 meses de salario + 200% del bono objetivo) y consolidación total si la terminación ocurre dentro de un año tras un cambio de control. Un comunicado de prensa (Ex. 99.1) fue presentado el 29 de julio de 2025.

eHealth, Inc. (EHTH)는 CEO 교체 계획을 알리는 8-K 보고서를 제출했습니다. 현 CEO인 Fran Soistman은 2025년 9월 18일 이사회 회의 직전에 즉시 사임하며, 2025년 12월 31일까지는 임원 고문으로 남을 예정입니다. 이사회는 Derrick Duke(58세), 전 Magellan Health CEO이자 HealthMarkets 전 CFO/COO를 후임 CEO 및 최고경영자로 임명했습니다. Duke는 2025년 8월 4일에 합류하여 인수인계를 시작하며, 이후 이사회 멤버십도 예상됩니다.

Duke의 제안서에는 다음이 포함됩니다: (i) 연간 기본급 70만 달러, (ii) 목표 연간 보너스 120%, (iii) 입사 보너스 60만 달러(1년 이내 퇴사 시 반환), (iv) 3년에 걸쳐 베스팅되는 30만 주 시간 기반 RSU와 3년 프로그램에 연동된 30만 주 성과 기반 RSU. 퇴직 합의서에는 ‘자격 있는 해고’ 시 24개월 급여, 비례 보너스, 최대 18개월 COBRA, 부분 또는 전액 주식 가속 조치가 포함되며, 인수 후 1년 이내 해고 시에는 현금 보상(24개월 급여 + 목표 보너스 200%)과 완전 베스팅이 제공됩니다. 2025년 7월 29일 보도자료(Ex. 99.1)가 제공되었습니다.

eHealth, Inc. (EHTH) a déposé un formulaire 8-K annonçant une transition prévue du PDG. L'actuel PDG, Fran Soistman, démissionnera immédiatement avant la réunion du conseil d'administration du 18 septembre 2025 et restera conseiller exécutif jusqu'au 31 décembre 2025. Le conseil a nommé Derrick Duke, 58 ans, ancien PDG de Magellan Health et ancien CFO/COO de HealthMarkets, comme PDG successeur et principal dirigeant. Duke rejoindra l'entreprise le 4 août 2025 pour commencer la passation; une adhésion au conseil est également attendue.

La lettre d'offre adressée à Duke prévoit : (i) un salaire de base annuel de 700 000 $, (ii) une prime annuelle cible de 120 %, (iii) une prime d'embauche de 600 000 $ (récupérable s'il quitte dans l'année), (iv) 300 000 RSU basées sur le temps avec acquisition sur trois ans et 300 000 RSU basées sur la performance liées à un programme de trois ans. Un accord de départ prévoit 24 mois de salaire, une prime au prorata, jusqu'à 18 mois de COBRA et une accélération partielle ou totale des actions en cas de « licenciement qualifié », avec une compensation en espèces améliorée (24 mois de salaire + 200 % de la prime cible) et une acquisition complète si le licenciement intervient dans l'année suivant un changement de contrôle. Un communiqué de presse (Ex. 99.1) a été publié le 29 juillet 2025.

eHealth, Inc. (EHTH) reichte ein 8-K ein, in dem ein geplanter CEO-Wechsel angekündigt wurde. Der aktuelle CEO Fran Soistman wird unmittelbar vor der Vorstandssitzung am 18. September 2025 zurücktreten und bis zum 31. Dezember 2025 als Executive Advisor verbleiben. Der Vorstand hat Derrick Duke, 58 Jahre alt, ehemaliger CEO von Magellan Health und ehemaliger CFO/COO von HealthMarkets, als Nachfolger und Hauptgeschäftsführer ernannt. Duke tritt am 4. August 2025 ein, um die Übergabe zu beginnen; eine Mitgliedschaft im Vorstand wird erwartet.

Dukes Angebotsbrief sieht vor: (i) ein jährliches Grundgehalt von 700.000 USD, (ii) eine Zieljahresbonus von 120 %, (iii) einen Einstiegsbonus von 600.000 USD (Rückforderung bei Ausscheiden innerhalb eines Jahres), (iv) 300.000 zeitbasierte RSUs, die über drei Jahre vesten, und 300.000 leistungsbasierte RSUs, die an ein dreijähriges Programm gebunden sind. Eine Abfindungsvereinbarung gewährt bei einer „qualifizierten Kündigung“ 24 Monate Gehalt, anteiligen Bonus, bis zu 18 Monate COBRA und teilweise oder vollständige Aktienbeschleunigung, mit erhöhtem Barbetrag (24 Monate Gehalt + 200 % Zielbonus) und vollständigem Vesting, falls die Kündigung innerhalb eines Jahres nach einer Kontrollwechsel erfolgt. Eine Pressemitteilung (Ex. 99.1) wurde am 29. Juli 2025 bereitgestellt.

Positive
  • Experienced industry leader appointed CEO; prior roles at Magellan Health and HealthMarkets bring relevant managed-care and distribution expertise.
  • Performance-weighted equity (300 k PRSUs) aligns a large portion of compensation with multi-year shareholder returns.
  • Orderly succession plan retains outgoing CEO as advisor through year-end, mitigating operational risk during transition.
Negative
  • Rich compensation and severance—$600 k sign-on, 24-month salary severance, and potential full equity acceleration—could pressure future expense and invite governance scrutiny.
  • Leadership change timing occurs close to Medicare annual enrollment period; execution missteps could affect near-term revenue if transition is not seamless.

Insights

TL;DR Veteran insurer executive named CEO; package rich but aligns pay with long-term stock performance; transition risk appears contained.

Analysis: Duke’s background at Magellan Health and HealthMarkets adds deep managed-care and distribution expertise relevant to eHealth’s Medicare brokerage model. Equity mix (50 % performance-based) ties compensation to multi-year operating goals, potentially improving shareholder alignment. Severance of 2× salary and accelerated vesting is typical for peer group and should not materially inflate contingency liabilities. Near-term costs rise (sign-on + RSUs), yet no change to financial guidance was disclosed, suggesting limited immediate P&L impact. Continuity is mitigated by Soistman remaining advisor for three months, reducing execution risk during AEP season.

TL;DR Governance neutral: orderly succession, robust disclosures, but sizable golden-parachute provisions warrant monitoring.

The Board concluded its search and disclosed all material terms, exhibiting transparency. Equity awards balance time- and performance-based criteria, supporting pay-for-performance philosophy. Nonetheless, 24-month salary severance plus full double-trigger vesting after a change-in-control ranks toward the upper end of small-cap norms, which investors may scrutinize if strategic activity arises. No related-party or family relationships were identified.

eHealth, Inc. (EHTH) ha presentato un modulo 8-K annunciando una prevista transizione del CEO. L'attuale CEO, Fran Soistman, si dimetterà immediatamente prima della riunione del Consiglio del 18 settembre 2025 e rimarrà come consulente esecutivo fino al 31 dicembre 2025. Il Consiglio ha nominato Derrick Duke, 58 anni, ex CEO di Magellan Health e ex CFO/COO di HealthMarkets, come nuovo CEO e principale dirigente esecutivo. Duke entrerà in carica il 4 agosto 2025 per iniziare il passaggio di consegne; è previsto anche il suo ingresso nel Consiglio.

La lettera di offerta a Duke prevede: (i) uno stipendio base annuo di 700.000 dollari, (ii) un bonus annuale target del 120%, (iii) un bonus di benvenuto di 600.000 dollari (con possibilità di restituzione se lascia entro un anno), (iv) 300.000 RSU basate sul tempo con maturazione in tre anni e 300.000 RSU basate sulle performance legate a un programma triennale. Un accordo di buonuscita garantisce 24 mesi di stipendio, bonus proporzionato, fino a 18 mesi di COBRA e accelerazione parziale o totale delle azioni in caso di “licenziamento qualificato”, con un aumento in denaro (24 mesi di stipendio + 200% del bonus target) e piena maturazione se il licenziamento avviene entro un anno da un cambio di controllo. Un comunicato stampa (Ex. 99.1) è stato fornito il 29 luglio 2025.

eHealth, Inc. (EHTH) presentó un formulario 8-K anunciando una transición planificada del CEO. El actual CEO, Fran Soistman, renunciará inmediatamente antes de la reunión de la Junta el 18 de septiembre de 2025 y permanecerá como asesor ejecutivo hasta el 31 de diciembre de 2025. La Junta ha nombrado a Derrick Duke, de 58 años, ex CEO de Magellan Health y ex CFO/COO de HealthMarkets, como sucesor y principal ejecutivo. Duke se incorporará el 4 de agosto de 2025 para iniciar la transición; se espera que también se una a la Junta.

La carta oferta para Duke incluye: (i) un salario base anual de 700,000 dólares, (ii) un bono anual objetivo del 120%, (iii) un bono de incorporación de 600,000 dólares (con devolución si se va en menos de un año), (iv) 300,000 RSU basadas en tiempo que se consolidan en tres años y 300,000 RSU basadas en desempeño vinculadas a un programa de tres años. Un acuerdo de indemnización ofrece 24 meses de salario, bono prorrateado, hasta 18 meses de COBRA y aceleración parcial o total de acciones en caso de una “terminación calificada”, con un beneficio en efectivo mejorado (24 meses de salario + 200% del bono objetivo) y consolidación total si la terminación ocurre dentro de un año tras un cambio de control. Un comunicado de prensa (Ex. 99.1) fue presentado el 29 de julio de 2025.

eHealth, Inc. (EHTH)는 CEO 교체 계획을 알리는 8-K 보고서를 제출했습니다. 현 CEO인 Fran Soistman은 2025년 9월 18일 이사회 회의 직전에 즉시 사임하며, 2025년 12월 31일까지는 임원 고문으로 남을 예정입니다. 이사회는 Derrick Duke(58세), 전 Magellan Health CEO이자 HealthMarkets 전 CFO/COO를 후임 CEO 및 최고경영자로 임명했습니다. Duke는 2025년 8월 4일에 합류하여 인수인계를 시작하며, 이후 이사회 멤버십도 예상됩니다.

Duke의 제안서에는 다음이 포함됩니다: (i) 연간 기본급 70만 달러, (ii) 목표 연간 보너스 120%, (iii) 입사 보너스 60만 달러(1년 이내 퇴사 시 반환), (iv) 3년에 걸쳐 베스팅되는 30만 주 시간 기반 RSU와 3년 프로그램에 연동된 30만 주 성과 기반 RSU. 퇴직 합의서에는 ‘자격 있는 해고’ 시 24개월 급여, 비례 보너스, 최대 18개월 COBRA, 부분 또는 전액 주식 가속 조치가 포함되며, 인수 후 1년 이내 해고 시에는 현금 보상(24개월 급여 + 목표 보너스 200%)과 완전 베스팅이 제공됩니다. 2025년 7월 29일 보도자료(Ex. 99.1)가 제공되었습니다.

eHealth, Inc. (EHTH) a déposé un formulaire 8-K annonçant une transition prévue du PDG. L'actuel PDG, Fran Soistman, démissionnera immédiatement avant la réunion du conseil d'administration du 18 septembre 2025 et restera conseiller exécutif jusqu'au 31 décembre 2025. Le conseil a nommé Derrick Duke, 58 ans, ancien PDG de Magellan Health et ancien CFO/COO de HealthMarkets, comme PDG successeur et principal dirigeant. Duke rejoindra l'entreprise le 4 août 2025 pour commencer la passation; une adhésion au conseil est également attendue.

La lettre d'offre adressée à Duke prévoit : (i) un salaire de base annuel de 700 000 $, (ii) une prime annuelle cible de 120 %, (iii) une prime d'embauche de 600 000 $ (récupérable s'il quitte dans l'année), (iv) 300 000 RSU basées sur le temps avec acquisition sur trois ans et 300 000 RSU basées sur la performance liées à un programme de trois ans. Un accord de départ prévoit 24 mois de salaire, une prime au prorata, jusqu'à 18 mois de COBRA et une accélération partielle ou totale des actions en cas de « licenciement qualifié », avec une compensation en espèces améliorée (24 mois de salaire + 200 % de la prime cible) et une acquisition complète si le licenciement intervient dans l'année suivant un changement de contrôle. Un communiqué de presse (Ex. 99.1) a été publié le 29 juillet 2025.

eHealth, Inc. (EHTH) reichte ein 8-K ein, in dem ein geplanter CEO-Wechsel angekündigt wurde. Der aktuelle CEO Fran Soistman wird unmittelbar vor der Vorstandssitzung am 18. September 2025 zurücktreten und bis zum 31. Dezember 2025 als Executive Advisor verbleiben. Der Vorstand hat Derrick Duke, 58 Jahre alt, ehemaliger CEO von Magellan Health und ehemaliger CFO/COO von HealthMarkets, als Nachfolger und Hauptgeschäftsführer ernannt. Duke tritt am 4. August 2025 ein, um die Übergabe zu beginnen; eine Mitgliedschaft im Vorstand wird erwartet.

Dukes Angebotsbrief sieht vor: (i) ein jährliches Grundgehalt von 700.000 USD, (ii) eine Zieljahresbonus von 120 %, (iii) einen Einstiegsbonus von 600.000 USD (Rückforderung bei Ausscheiden innerhalb eines Jahres), (iv) 300.000 zeitbasierte RSUs, die über drei Jahre vesten, und 300.000 leistungsbasierte RSUs, die an ein dreijähriges Programm gebunden sind. Eine Abfindungsvereinbarung gewährt bei einer „qualifizierten Kündigung“ 24 Monate Gehalt, anteiligen Bonus, bis zu 18 Monate COBRA und teilweise oder vollständige Aktienbeschleunigung, mit erhöhtem Barbetrag (24 Monate Gehalt + 200 % Zielbonus) und vollständigem Vesting, falls die Kündigung innerhalb eines Jahres nach einer Kontrollwechsel erfolgt. Eine Pressemitteilung (Ex. 99.1) wurde am 29. Juli 2025 bereitgestellt.

false 0001865602 0001865602 2025-07-26 2025-07-26 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 29, 2025 (July 26, 2025)

 

CANTOR EQUITY PARTNERS, INC.

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-42250   98-1576482
(State or other jurisdiction
of incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

110 East 59th Street, New York, NY   10022
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (212) 938-5000

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A ordinary shares, par value $0.0001 per share   CEP   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 1.01 Entry into a Material Definitive Agreement.

 

As previously reported on Current Reports on Form 8-K filed with the United States Securities and Exchange Commission (the “SEC”), on April 22, 2025, Cantor Equity Partners, Inc., a Cayman Islands exempted company (“CEP”), entered into a Business Combination Agreement (the “Business Combination Agreement”) with Twenty One Capital, Inc., a Texas corporation (“Pubco”), Twenty One Merger Sub D, a Cayman Islands exempted company, Twenty One Assets, LLC, a Delaware limited liability company (“Twenty One”), Tether Investments, S.A. de C.V., an El Salvador sociedad anónima de capital variable (“Tether”), iFinex, Inc., a British Virgin Islands company, and, solely for the purposes of certain provisions in the Business Combination Agreement, Stellar Beacon LLC, a Delaware limited liability company, for a proposed business combination (the “Business Combination”).

 

On July 26, 2025, the parties to the Business Combination Agreement entered into Amendment No. 1 to the Business Combination Agreement (“Amendment No. 1 to the Business Combination Agreement”), which amends the Business Combination Agreement, to among other things, provide that the Additional PIPE Bitcoin Purchase Price (as defined in the Business Combination Agreement) used to determine the value of Tether’s contribution of the Additional PIPE Bitcoin (as defined in the Business Combination Agreement) to Pubco at the Closing and the number of shares of Pubco Stock (as defined in the Business Combination Agreement) to be issued to Tether at the Closing in exchange for the sale of the Additional PIPE Bitcoin by Tether to Pubco shall be based on the Signing Bitcoin Price of $84,863.57, rather than on the aggregate amount Tether paid to purchase the Additional PIPE Bitcoin.

 

Amendment No. 1 to the Business Combination Agreement is filed as Exhibit 2.1 to this Current Report on Form 8-K, and the foregoing description thereof is qualified in its entirety by reference to the full text of Amendment No. 1 to the Business Combination Agreement and the terms of which are incorporated by reference herein.

 

Item 8.01 Other Events.

 

On July 29, 2025, Pubco issued a press release announcing that at the closing of the Business Combination it will receive approximately 5,800 additional Bitcoin from Tether bringing Pubco’s expected total holdings at such closing to 43,500 Bitcoin. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.

 

Additional Information and Where to Find It

 

Pubco and Twenty One have submitted confidentially a Registration Statement on Form S-4 (as may be amended, the “Registration Statement”) and intend to file publicly with the SEC the Registration Statement, which will include a preliminary proxy statement of CEP and a prospectus (the “Proxy Statement/Prospectus”) in connection with the Business Combination and certain convertible senior secured notes offering and common equity PIPE financings (the “PIPE Offerings” and, together with the Business Combination, the “Proposed Transactions”). The definitive proxy statement and other relevant documents will be mailed to shareholders of CEP as of a record date to be established for voting on the Business Combination and other matters as described in the Proxy Statement/Prospectus. CEP and/or Pubco will also file other documents regarding the Proposed Transactions with the SEC. This Report does not contain all of the information that should be considered concerning the Proposed Transactions and is not intended to form the basis of any investment decision or any other decision in respect of the Proposed Transactions. BEFORE MAKING ANY VOTING OR INVESTMENT DECISION, SHAREHOLDERS OF CEP AND OTHER INTERESTED PARTIES ARE URGED TO READ, WHEN AVAILABLE, THE PRELIMINARY PROXY STATEMENT/PROSPECTUS, AND AMENDMENTS THERETO, AND THE DEFINITIVE PROXY STATEMENT/PROSPECTUS AND ALL OTHER RELEVANT DOCUMENTS FILED OR THAT WILL BE FILED WITH THE SEC IN CONNECTION WITH CEP’S SOLICITATION OF PROXIES FOR THE EXTRAORDINARY GENERAL MEETING OF ITS SHAREHOLDERS TO BE HELD TO APPROVE THE PROPOSED TRANSACTIONS AND OTHER MATTERS AS DESCRIBED IN THE PROXY STATEMENT/PROSPECTUS BECAUSE THESE DOCUMENTS WILL CONTAIN IMPORTANT INFORMATION ABOUT CEP, TWENTY ONE, PUBCO AND THE PROPOSED TRANSACTIONS. Investors and security holders will also be able to obtain copies of the Registration Statement and the Proxy Statement/Prospectus and all other documents filed or that will be filed with the SEC by CEP and Pubco, without charge, once available, on the SEC’s website at www.sec.gov or by directing a request to: Cantor Equity Partners, Inc., 110 East 59th Street, New York, NY 10022; e-mail: CantorEquityPartners@cantor.com, or upon written request to Twenty One Capital, Inc., via email at info@xxi.money, respectively.

 

1

 

 

NEITHER THE SEC NOR ANY STATE SECURITIES REGULATORY AGENCY HAS APPROVED OR DISAPPROVED THE PROPOSED TRANSACTIONS DESCRIBED HEREIN, PASSED UPON THE MERITS OR FAIRNESS OF THE PROPOSED TRANSACTIONS OR ANY RELATED TRANSACTIONS OR PASSED UPON THE ADEQUACY OR ACCURACY OF THE DISCLOSURE IN THIS REPORT. ANY REPRESENTATION TO THE CONTRARY CONSTITUTES A CRIMINAL OFFENSE.

 

The convertible notes of Pubco and the CEP Class A ordinary shares to be issued in the PIPE Offerings have not been registered under the Securities Act of 1933, as amended (the “Securities Act”) and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act.

 

Participants in the Solicitation

 

CEP, Twenty One, Pubco and their respective directors, executive officers, certain of their shareholders and other members of management and employees may be deemed under SEC rules to be participants in the solicitation of proxies from CEP’s shareholders in connection with the Proposed Transactions. A list of the names of such persons, and information regarding their interests in the Proposed Transactions and their ownership of CEP’s securities are, or will be, contained in CEP’s filings with the SEC, including CEP’s Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 28, 2025. Additional information regarding the interests of the persons who may, under SEC rules, be deemed participants in the solicitation of proxies of CEP’s shareholders in connection with the Proposed Transactions, including the names and interests of the directors and executive officers of CEP, Twenty One and Pubco, will be set forth in the Registration Statement and Proxy Statement/Prospectus, which is expected to be filed with the SEC. Investors and security holders may obtain free copies of these documents as described above.

 

No Offer or Solicitation

 

The information contained in this Report is for informational purposes only and is not a proxy statement or solicitation of a proxy, consent or authorization with respect to any securities or in respect of the Proposed Transactions and shall not constitute an offer to sell or exchange, or a solicitation of an offer to buy or exchange the securities of CEP, Twenty One or Pubco, or any commodity or instrument or related derivative, nor shall there be any sale of any such securities in any state or jurisdiction in which such offer, solicitation, sale or exchange would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction. No offer of securities shall be made except by means of a prospectus meeting the requirements of the Securities Act or an exemption therefrom. Investors should consult with their counsel as to the applicable requirements for a purchaser to avail itself of any exemption under the Securities Act.

 

2

 

 

Forward-Looking Statements

 

This Report contains certain forward-looking statements within the meaning of the U.S. federal securities laws with respect to the Proposed Transactions involving CEP, Pubco and Twenty One, including expectations, intentions, plans, prospects regarding CEP, Pubco, Twenty One and the Proposed Transactions and statements regarding the anticipated timing of the completion of the Proposed Transactions, assets held by Pubco, use of proceeds and the satisfaction of closing conditions to the Proposed Transactions. These forward-looking statements generally are identified by the words “believe,” “project,” “expect,” “anticipate,” “estimate,” “intend,” “strategy,” “future,” “opportunity,” “potential,” “plan,” “may,” “should,” “will,” “would,” “will be,” “will continue,” “will likely result,” and similar expressions. Forward-looking statements are predictions, projections and other statements about future events or conditions that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this Report, including, but not limited to: the risk that the Proposed Transactions may not be completed in a timely manner or at all, which may adversely affect the price of CEP’s securities; the risk that the Proposed Transactions may not be completed by CEP’s business combination deadline; the failure by the parties to satisfy the conditions to the consummation of the Business Combination, including the approval of CEP’s shareholders, or any of the PIPE Offerings; failure to realize the anticipated benefits of the Proposed Transactions; the level of redemptions of CEP’s public shareholders which may reduce the public float of, reduce the liquidity of the trading market of, and/or maintain the quotation, listing, or trading of the CEP Class A ordinary shares or the shares of Class A common stock of Pubco, par value $0.01 per share (“Pubco Class A Stock”); the lack of a third-party fairness opinion in determining whether or not to pursue the Business Combination; the failure of Pubco to obtain or maintain the listing of its securities on any securities exchange after closing of the Proposed Transactions; costs related to the Proposed Transactions and as a result of becoming a public company; changes in business, market, financial, political and regulatory conditions; risks relating to Pubco’s anticipated operations and business, including the highly volatile nature of the price of Bitcoin; the risk that Pubco’s stock price will be highly correlated to the price of Bitcoin and the price of Bitcoin may decrease between the signing of the definitive documents for the Proposed Transactions and the closing of the Proposed Transactions or at any time after the closing of the Proposed Transactions; risks related to increased competition in the industries in which Pubco will operate; risks relating to significant legal, commercial, regulatory and technical uncertainty regarding Bitcoin; risks relating to the treatment of crypto assets for U.S. and foreign tax purposes; risks that after consummation of the Proposed Transactions, Pubco experiences difficulties managing its growth and expanding operations; the risks that growing Pubco’s learning programs and educational content could be difficult; challenges in implementing Pubco’s business plan including Bitcoin-related financial and advisory services, due to operational challenges, significant competition and regulation; the outcome of any potential legal proceedings that may be instituted against CEP, Pubco, Twenty One or others following announcement of the Proposed Transactions, and those risk factors discussed in documents that CEP, Pubco and/or Twenty One filed, or that will be filed, with the SEC.

 

The foregoing list of risk factors is not exhaustive. You should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” section of the final prospectus of CEP, dated as of August 12, 2024 and filed by CEP with the SEC on August 13, 2024, CEP’s Quarterly Reports on Form 10-Q, CEP’s Annual Report on Form 10-K and the Registration Statement that will be filed by Pubco and Twenty One and the Proxy Statement/Prospectus contained therein, and other documents filed by CEP, Twenty One and Pubco from time to time with the SEC. These filings do or will identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements. There may be additional risks that neither CEP, Twenty One nor Pubco presently know or that CEP, Twenty One and Pubco currently believe are immaterial that could also cause actual results to differ from those contained in the forward-looking statements.

 

Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and each of CEP, Twenty One and Pubco assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise. Neither CEP, Twenty One nor Pubco gives any assurance that either CEP, Twenty One or Pubco will achieve its expectations. The inclusion of any statement in this Report does not constitute an admission by CEP, Twenty One or Pubco or any other person that the events or circumstances described in such statement are material.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits.

 

Exhibit No.   Description
2.1   Amendment No.1 to the Business Combination Agreement, dated as of July 26, 2025, by and among CEP, SPAC Merger Sub, Pubco, Twenty One, the Sellers and, for certain limited purposes, SoftBank.
99.1   Press Release, dated July 29, 2025.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

3

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: July 29, 2025

 

  CANTOR EQUITY PARTNERS, INC.
   
  By: /s/ Brandon Lutnick
  Name:  Brandon Lutnick
  Title: Chief Executive Officer

 

 

4

 

FAQ

When will Derrick Duke officially become CEO of eHealth (EHTH)?

Mr. Duke will assume the CEO role immediately after the Board meeting on 18 Sep 2025, following his onboarding start date of 4 Aug 2025.

What is Derrick Duke’s compensation package at eHealth?

He receives $700 k salary, 120 % target bonus, a $600 k sign-on bonus, 300 k time-based RSUs and 300 k performance-based RSUs.

What severance benefits could the new eHealth CEO receive?

A qualifying termination yields a lump-sum of 24 months’ salary, prorated bonus, up to 18 months COBRA, and partial equity acceleration; enhanced benefits apply after a change-in-control.

What role will outgoing CEO Fran Soistman have after resigning?

Mr. Soistman will serve as an executive advisor from the CEO change date until 31 Dec 2025.

Did eHealth disclose any related-party transactions with Derrick Duke?

No. The filing states there are no related-party transactions or family relationships requiring disclosure under Regulation S-K.
Cantor Equity Partners Inc-A

NASDAQ:CEP

CEP Rankings

CEP Latest News

CEP Latest SEC Filings

CEP Stock Data

369.41M
10.00M
2.91%
85.56%
0.05%
Shell Companies
Blank Checks
United States
NEW YORK